Get Next-Level Biotechnology Exposure with the “GDNA” ETF

The coronavirus pandemic is certainly putting healthcare in the spotlight, but it’s also putting biotechnology under the proverbial microscope, particularly when it comes to finding a vaccine. As such, exchange-traded fund (ETF) investors can get next-level biotech exposure with funds like the...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.